Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000367982 | SCV000751855 | likely benign | Fanconi anemia | 2025-01-17 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000658691 | SCV000780477 | uncertain significance | not provided | 2017-12-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000658691 | SCV001822648 | uncertain significance | not provided | 2024-11-18 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Observed in individuals with personal or family history of breast or ovarian cancer, but also in unaffected controls (PMID: 36315097, 28881617, 22347400, 33471991); This variant is associated with the following publications: (PMID: 28881617, 22347400, 36315097, 33471991) |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000658691 | SCV004218816 | likely benign | not provided | 2023-01-16 | criteria provided, single submitter | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV000658691 | SCV001553974 | uncertain significance | not provided | no assertion criteria provided | clinical testing | The FANCM p.His1703Arg variant was not identified in the literature nor was it identified in Cosmic. The variant was identified in dbSNP (ID: rs146897650), LOVD 3.0 and in ClinVar (classified as a VUS for Fanconi Anemia by Illumina, Invitae and Praxis fuer Humangenetik Tuebingen). The variant was identified in control databases in 85 of 282664 chromosomes at a frequency of 0.000301 (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: Ashkenazi Jewish in 67 of 10364 chromosomes (freq: 0.006465), Other in 4 of 7218 chromosomes (freq: 0.000554) and European (non-Finnish) in 14 of 128998 chromosomes (freq: 0.000109); it was not observed in the African, Latino, East Asian, European (Finnish), and South Asian populations. The p.His1703 residue is not conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; however, this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, and GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. |